1. Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590). Issue 23 (7th August 2017) Authors: Bhatia, Aarti K.; Lee, Ju‐Whei; Pinto, Harlan A.; Jacobs, Charlotte D.; Limburg, Paul J.; Rubin, Philip; Arusell, Robert M.; Dunphy, Eamonn P.; Khandekar, Janardan D.; Reiner, Seth A.; Baez‐Diaz, Luis; Celano, Paul; Li, Shuli; Li, Yi; Burtness, Barbara A.; Adams, George L.; Pandya, Kishan J. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Issue 7 (7th December 2012) Authors: Ho, Allen S.; Tsao, Gabriel J.; Chen, Frank W.; Shen, Tianjie; Kaplan, Michael J.; Colevas, A. Dimitrios; Fischbein, Nancy J.; Quon, Andrew; Le, Quynh‐Thu; Pinto, Harlan A.; Fee, Willard E.; Sunwoo, John B.; Sirjani, Davud; Hara, Wendy; Yao, Mike Journal: Cancer Issue: Volume 119:Issue 7(2013) Page Start: 1349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗